A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism.

M Miyoshi; M Mizuno; K Ishiki; Y Nagahara; T Maga; T Torigoe; J Nasu; H Okada; K Yokota; K Oguma

doi:10.1046/j.1440-1746.2001.02526.x

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism.

Identifier:nobleid.org/w1/20260515/84DFF9C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/84DFF9C2.svg?ark=w1%2F20260515%2F84DFF9C2)](https://nobleid.org/work/w1/20260515/84DFF9C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism.

Identifier:nobleid.org/w1/20260515/84DFF9C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/84DFF9C2.svg?ark=w1%2F20260515%2F84DFF9C2)](https://nobleid.org/work/w1/20260515/84DFF9C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work